Weak momentum hits Injective: Can INJ avoid deeper losses?

Traders Union
All News
Crypto
Injective drops 7.09% today to $4.89

Highlights

Injective targets institutional adoption by expanding compliant blockchain solutions for real-world asset tokenization amid regulatory progress in the US and Europe.
Recent legal clarity boosts prospects for institutional participation in crypto tokenization, but INJ faces broad-based selling pressure.
INJ/USD shows persistent bearish momentum with strong selling signals; expected to trade between $4.78 and $5.29, downside extension likely if support breaks.

Institutional demand seen rising as regulatory clarity improves

Injective is expanding its capabilities in real-world asset tokenization by offering compliant blockchain infrastructure targeted at institutional clients. This effort is accompanied by recent regulatory advancements in both the United States and Europe, which support further growth in the sector and provide greater legal clarity for institutional participants, according to Tronweekly. These factors have the potential to increase institutional demand for the Injective platform, though price action has remained under broader selling pressure.

Downward momentum persists while long-term support holds

Technically, INJ/USD is trading below both the MA-20 and MA-50 on the hourly timeframe, with the MA-200 providing underlying long-term support. The Ichimoku Kijun line at $5.18 acts as immediate resistance, delineating a key level that traders are watching for a potential reversal. Momentum indicators remain negative: MACD and ADX confirm selling pressure, while RSI, Stoch RSI, and CCI all indicate oversold or persistent sell conditions. Bull/Bear Power highlights ongoing seller dominance, and the Awesome Oscillator continues to show a prevailing downtrend.

Downside risk elevated as volatility band pressures price

Over the next two to three trading days, INJ/USD is expected to fluctuate within a volatility band from $4.78 to $5.29. The probability of a downside move is significantly higher than that of a rebound, making further selling the baseline scenario. Should the price break above immediate resistance near $5.18, a move toward the top of the expected range is possible; conversely, a break below $4.78 would likely accelerate losses beyond current support.

Anton Kharitonov, expert at Traders Union, notes that Injective is expanding institutional infrastructure at a critical time for regulatory clarity in both the United States and Europe. He sees this as a structural positive, but highlights that negative technical momentum and persistent selling pressure cloud the immediate outlook. Kharitonov remains cautious due to weak price action and oversold signals. “Until INJ/USD recovers above resistance at $5.18, my base case remains further downside within the current range,” the analyst concludes.

Earlier, analysts noted that Injective was exhibiting mixed momentum as it consolidated in a range amid uncertain breakout risks. With intensified selling pressure now dominating and key short-term indicators signaling continued weakness, traders should watch for heightened downside risk if support near $4.78 fails to hold in the coming sessions.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.